115 related articles for article (PubMed ID: 6253094)
1. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
Walker MD; Strike TA
Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
[TBL] [Abstract][Full Text] [Related]
2. Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
Schwade JG; Makuch RW; Strong JM; Glatstein E
Cancer Treat Rep; 1982 Sep; 66(9):1743-50. PubMed ID: 6288238
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentration of misonidazole and peripheral neuropathy.
Marten TR
Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
[No Abstract] [Full Text] [Related]
4. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.
Saunders ME; Dische S; Anderson P; Flockhart IR
Br J Cancer Suppl; 1978 Jun; 3():268-70. PubMed ID: 209808
[TBL] [Abstract][Full Text] [Related]
5. Peripheral neuropathy related to misonidazole: incidence and pathology.
Urtasun RC; Chapman JD; Feldstein ML; Band RP; Rabin HR; Wilson AF; Marynowski B; Starreveld E; Shnitka T
Br J Cancer Suppl; 1978 Jun; 3():271-5. PubMed ID: 209809
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
Bamberg M; Tamulevicius P; Streffer C; Scherer E
Strahlentherapie; 1981 Aug; 157(8):524-36. PubMed ID: 7268822
[No Abstract] [Full Text] [Related]
7. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
Bleehen NM
Cancer Clin Trials; 1980; 3(3):267-73. PubMed ID: 7002338
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of misonidazole.
Notter G; Rylander U; Turesson I
Strahlentherapie; 1980; 156(10):714-8. PubMed ID: 7434379
[TBL] [Abstract][Full Text] [Related]
9. Misonidazole neuropathy.
Paulson OB; Melgaard B; Hansen HS; Kamieniecka Z; Køhler O; Hansen JM; Pedersen AG; Tang X; Trojaborg W
Acta Neurol Scand Suppl; 1984; 100():133-6. PubMed ID: 6091392
[TBL] [Abstract][Full Text] [Related]
10. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.
Jones DH; Bleehen NM; Workman P; Smith NC
Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with misonidazole: high dose fractions versus daily low doses.
Kogelnik HD
Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
[TBL] [Abstract][Full Text] [Related]
12. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
Wasserman TH; Phillips TL; Van Raalte G; Urtasun R; Partington J; Koziol D; Schwade JG; Gangji D; Strong JM
Br J Radiol; 1980 Feb; 53(626):172-3. PubMed ID: 6245744
[No Abstract] [Full Text] [Related]
13. New side effect of the hypoxic cell sensitizer, misonidazole.
Partington J; Koziol D; Chapman D; Rabin H; Urtasun RC
Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials of misonidazole in the United States.
Wasserman TH; Stetz J; Phillips TL
Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
[TBL] [Abstract][Full Text] [Related]
16. Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
Melgaard B; Hansen HS; Kamieniecka Z; Paulson OB; Pedersen AG; Tang X; Trojaborg W
Ann Neurol; 1982 Jul; 12(1):10-7. PubMed ID: 7114817
[TBL] [Abstract][Full Text] [Related]
17. Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16?
Nelson DF; Gillespie BW; Diener MD; Davis DR; Wasserman T; Phillips TL; Stetz J
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1731-4. PubMed ID: 6384162
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with daily doses of misonidazole (author's transl)].
Kogelnik HD; Reinartz G; Szepesi T; Seitz W; Wurst F; Mamoli B; Wessely P; Stark H
Strahlentherapie; 1980 Nov; 156(11):758-64. PubMed ID: 7434385
[TBL] [Abstract][Full Text] [Related]
19. Misonidazole in patients receiving radical radiotherapy: pharmacokinetic effects of phenytoin, tumor response and neurotoxicity.
Moore JL; Paterson IC; Dawes PJ; Henk JM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):361-4. PubMed ID: 7107352
[TBL] [Abstract][Full Text] [Related]
20. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
